These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12454566)

  • 21. Clinical outcome and plasma levels of clozapine and norclozapine in drug-resistant schizophrenic patients.
    Mauri M; Volonteri LS; Fiorentini A; Invernizzi G; Nerini T; Baldi M; Bareggi SR
    Schizophr Res; 2004 Feb; 66(2-3):197-8. PubMed ID: 15061256
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharmacotherapy of chronic schizophrenic psychoses--neuroleptic plus serotonin reuptake inhibitor?].
    Salzmann E; Eikelmann B
    Psychiatr Prax; 1997 Sep; 24(5):253. PubMed ID: 9417552
    [No Abstract]   [Full Text] [Related]  

  • 23. Carbamazepine and/or fluvoxamine drug interaction with risperidone in a patient on multiple psychotropic medications.
    Alfaro CL; Nicolson R; Lenane M; Rapoport JL
    Ann Pharmacother; 2000 Jan; 34(1):122-3. PubMed ID: 10669197
    [No Abstract]   [Full Text] [Related]  

  • 24. Fluvoxamine-clozapine interaction: time-dependent?
    Lu ML; Lane HY; Chang WH
    J Clin Psychopharmacol; 2002 Aug; 22(4):439-40. PubMed ID: 12172350
    [No Abstract]   [Full Text] [Related]  

  • 25. Ibuprofen May Increase Pharmacological Action of Valproate by Displacing It From Plasma Proteins: A Case Report.
    Lana F; Martí-Bonany J; de Leon J
    Am J Psychiatry; 2016 Sep; 173(9):941-2. PubMed ID: 27581700
    [No Abstract]   [Full Text] [Related]  

  • 26. High-Dose Fluvoxamine Augmentation to Clozapine in Treatment-Resistant Psychosis.
    Leising J; Barr AM; Procyshyn RM; Ainsworth NJ; White RF; Honer W; Vila-Rodriguez F
    J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):186-190. PubMed ID: 33587389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-administration of citalopram and clozapine: effect on plasma clozapine levels.
    Taylor D; Ellison Z; Ementon Shaw L; Wickham H; Murray R
    Int Clin Psychopharmacol; 1998 Jan; 13(1):19-21. PubMed ID: 9988363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clozapine-resistant schizophrenia related to an increased metabolism and benefit of fluvoxamine: four case reports].
    Papetti F; Morel-Pingault V; Buisse V; Maziere L; Banayan M; Thauby S; Besnard T; Darcourt G; Pringuey D
    Encephale; 2007 Oct; 33(5):811-8. PubMed ID: 18357853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Molecular pharmacogenetic study on antipsychotic-drug therapy responders with depression or schizophrenia].
    Suzuki Y; Sawamura H; Someya T
    Seishin Shinkeigaku Zasshi; 2006; 108(6):633-41. PubMed ID: 16910543
    [No Abstract]   [Full Text] [Related]  

  • 30. Comments on article by Albers et al: "Low-dose fluvoxamine as an adjunct to reduce olanzapine therapeutic dose requirements: a prospective dose-adjusted drug interaction strategy".
    Chiu CC; Lu ML
    J Clin Psychopharmacol; 2005 Dec; 25(6):626-7; author reply 627-8. PubMed ID: 16282861
    [No Abstract]   [Full Text] [Related]  

  • 31. Treating depression in schizophrenia.
    Lund BC; Perry PJ; Miller DD
    Am J Psychiatry; 2001 Sep; 158(9):1528-9. PubMed ID: 11532750
    [No Abstract]   [Full Text] [Related]  

  • 32. Health care utilization in patients with schizophrenia maintained on atypical versus conventional antipsychotics.
    Remington G; Khramov I
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Feb; 25(2):363-9. PubMed ID: 11294482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible increased efficacy of low-dose clozapine when combined with aripiprazole.
    Lim S; Pralea C; Schnitt J; Bowers MB; Cooper C
    J Clin Psychiatry; 2004 Sep; 65(9):1284-5. PubMed ID: 15367059
    [No Abstract]   [Full Text] [Related]  

  • 34. Relationship between patient variables and plasma clozapine concentrations: a dosing nomogram.
    Perry PJ; Bever KA; Arndt S; Combs MD
    Biol Psychiatry; 1998 Oct; 44(8):733-8. PubMed ID: 9798077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma clozapine concentration coefficients of variation in a long-term study.
    Diaz FJ; de Leon J; Josiassen RC; Cooper TB; Simpson GM
    Schizophr Res; 2005 Jan; 72(2-3):131-5. PubMed ID: 15560958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clozapine versus risperidone in treatment-refractory schizophrenia: possible impact of dosing strategies.
    Lane HY; Chang WH
    J Clin Psychiatry; 1999 Jul; 60(7):487-8. PubMed ID: 10453806
    [No Abstract]   [Full Text] [Related]  

  • 37. Therapeutic drug monitoring-based clozapine dosing recommendations.
    Zernig G; Ng K; Hiemke C; Saria A
    Ther Drug Monit; 2007 Feb; 29(1):130-1. PubMed ID: 17304162
    [No Abstract]   [Full Text] [Related]  

  • 38. Does adding a second antipsychotic to clozapine improve clinical response in resistant schizophrenia?
    Jiménez-Cornejo M; Munizaga G; Aceituno D
    Medwave; 2016 Dec; 16(Suppl5):e6614. PubMed ID: 27922589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Add-on fluvoxamine treatment for schizophrenia: an updated meta-analysis of randomized controlled trials.
    Kishi T; Hirota T; Iwata N
    Eur Arch Psychiatry Clin Neurosci; 2013 Dec; 263(8):633-41. PubMed ID: 23605347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. When treating patients with schizophrenia, what clinical points should be considered if lamotrigine is chosen to augment clozapine?
    Dursun SM; Devarajan S
    J Psychiatry Neurosci; 2001 Mar; 26(2):168. PubMed ID: 11496920
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.